erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Asthenia D001247 5 associated lipids
Ataxia D001259 20 associated lipids
Auditory Diseases, Central D001304 2 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Balanitis D001446 4 associated lipids
Bartonella Infections D001474 3 associated lipids
Bile Reflux D001655 2 associated lipids
Birth Weight D001724 23 associated lipids
Bites, Human D001734 2 associated lipids
Blepharitis D001762 4 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Resorption D001862 7 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchopneumonia D001996 7 associated lipids
Bundle-Branch Block D002037 2 associated lipids
Bursitis D002062 3 associated lipids
Campylobacter Infections D002169 13 associated lipids
Carbuncle D002270 1 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Uterine Cervical Erosion D002579 2 associated lipids
Uterine Cervical Incompetence D002581 3 associated lipids
Chancroid D002602 4 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Choanal Atresia D002754 1 associated lipids
Cholelithiasis D002769 16 associated lipids
Cholestasis D002779 23 associated lipids
Choline Deficiency D002796 16 associated lipids
Chorioamnionitis D002821 5 associated lipids
Choroiditis D002833 1 associated lipids
Chronic Disease D002908 7 associated lipids
Cleft Palate D002972 9 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Common Cold D003139 2 associated lipids
Compartment Syndromes D003161 1 associated lipids
Conjunctivitis D003231 7 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Constipation D003248 8 associated lipids
Corneal Diseases D003316 13 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Crohn Disease D003424 12 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dacryocystitis D003607 1 associated lipids
Death, Sudden D003645 12 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diarrhea D003967 32 associated lipids
Diarrhea, Infantile D003968 3 associated lipids
Digestive System Abnormalities D004065 1 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Dry Socket D004368 3 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dysarthria D004401 2 associated lipids
Dysentery, Bacillary D004405 6 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Edema D004487 152 associated lipids
Elephantiasis D004604 2 associated lipids
Empyema D004653 3 associated lipids
Endocarditis D004696 4 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Ermol'eva ZV et al. [Sensitivity of non-agglutinating vibrions to antibiotics]. 1969 Antibiotiki pmid:4185523
Zak AF et al. [Acute toxicity, cytotoxic and local irritating effect of antibiotics of different chemical groups]. 1971 Antibiotiki pmid:4943415
Garanin BA et al. [Sensitivity to antibiotics of Salmonella, Shigella, pathogenic Escherichia ia proteus isolated in the city of GorkiÄ­ during 1966-1968]. 1971 Antibiotiki pmid:4943417
Totolian AA et al. [Plasmid-determined streptococcal resistance to antibiotics]. 1979 Antibiotiki pmid:375817
Rachovskaia IuK and Rodionova NS [The antibiotic sensitivity spectrum of strains of salmonella circulating in Rostov-on-Don]. 1974 Antibiotiki pmid:4282564
Vartanian ZhS [The eliminating effect of rifampicin and acriflavine on the determinants of antibiotics resistance in clinical strains of staphylococcus]. 1973 Antibiotiki pmid:4493701
Val'vachev NI et al. [Correlation between the antibiotic sensitivity and phage group affiliation of pathogenic staphylococci]. 1974 Antibiotiki pmid:4282565
Shenderov BA et al. [Distribution of drug resistance and phage types of Staph. aureus isolated from clinical material of different origin]. 1970 Antibiotiki pmid:4249910
Red'ko AF [Dynamics of the change of the composition of microflora and its sensitivity toward antibiotics in purulent inflammatory processes of lungs]. 1966 Antibiotiki pmid:4385185
Zak AF et al. [Evaluation of the harmlessness of erythromycin according to various tests]. 1965 Antibiotiki pmid:5881056
Fomina IP and Lobuseva AN [Kinetic specification of some antibiotics in cases with kidney insufficiency]. 1972 Antibiotiki pmid:5023462
Lopatin AI [Erythromycin in the treatment of non-gonorrheal urethritis in males]. 1965 Antibiotiki pmid:5887636
VEIS RA and STOROZHEV Ia [On the pharmacology of erythromycin and its derivatives]. 1962 Antibiotiki pmid:13996561
MartinevskiÄ­ IL et al. [Trial use of polymyxin and erythromycin for isolating cultures of the plague microbe in the Kyzyl-Kum]. 1982 Antibiotiki pmid:6295257
Milich MV [Treatment of syphilis with antibiotics (the history, status of the problem and prospects)]. 1978 Antibiotiki pmid:360983
Buniatova IM et al. [Study of the action of some antibiotics in combination with the new sulfanilamide compound sulfapyridazine during the acute course of experimental staphylococcal infection]. 1966 Antibiotiki pmid:5184685
Postnikova AA and Kazakov GM [Sequestrotomy combined with antibiotic therapy in treatment of chronic osteomyelitis in children]. 1966 Antibiotiki pmid:5184686
Buniatova IM et al. [Study of the effect of some antibiotics in combination with the new sulfanilamide preparation sulfapyridazine in experimental chronic staphylococcal infection]. 1966 Antibiotiki pmid:5185627
Liashenko IuI [Effect of penicillin and erythromycin on immunity in angina]. 1982 Antibiotiki pmid:6980620
Klimova NE [Study of the absorption and distribution of erythromycin, oleandomycin, tetracycline and oletetrin on the experimental model (chick embryos)]. 1967 Antibiotiki pmid:4970743
Voropaeva SD et al. [Multiple resistance to antibiotics in clinical strains of staphylococci]. 1970 Antibiotiki pmid:5203378
Iats'ko VA [On the dynamics of sensitivity to antibiotics of different microorganisms, isolated from patients of a surgical section]. 1968 Antibiotiki pmid:4971186
Solov'ev VN and Shiolva SV [Comparative study of the levels of erythromycin resistance in Staphylococcus according to data from agar diffusion and serial dilution methods]. 1974 Antibiotiki pmid:4218070
Koroleva VG et al. [Effect of acid protective coating on absorption of erythromycin at oral administration]. 1969 Antibiotiki pmid:5371175
Krasnogolovets VN [Pseudomembraneous enterocolitis in the treatment of patients with antibiotics]. 1969 Antibiotiki pmid:5378166
VAKULENKO NA [Determination of erythromycin in serum and urine by the agar diffusion method]. 1961 Antibiotiki pmid:13779655
Ponomareva TR and Smolianskaia AZ [Prevalence of markers characteristic for penicillinase plasmids in clinical strains of straphylococci]. 1976 Antibiotiki pmid:952503
Vasina TA et al. [Effect of polysynthetic penicillins on causative agents of surgical infections in vitro]. 1970 Antibiotiki pmid:4195834
Solov'ev VN and Shilova SV [Mathematical model for the control and standardization of discs]. 1975 Antibiotiki pmid:1225183
Afanas'ev BA et al. [Comparative sensitivity in vitro to penicillin and erythromycin of gonococci isolated in 1965-1966 and 1971]. 1972 Antibiotiki pmid:4197809
Bibikova MV et al. [On the suppression of protein synthesis and stimulation of RNA synthesis during the action of some antibiotics on Bacillus subtilis mutants]. 1969 Antibiotiki pmid:4979790
Koniaev GA and Pavlov EP [Effect of polymyxin M on transduction of drug resistance factors in Staphylococcus aureus]. 1972 Antibiotiki pmid:4338057
Bass TM [Synergistic and antagonistic effect of combinations of antibacterial drugs on typhoid bacteria sensitive and resistant to antibiotics]. 1972 Antibiotiki pmid:4340590
SAVITSKAIA EP [A METHOD FOR THE DETERMINATION OF THE ANTIBIOTIC SENSITIVITY OF RICKETTSIA BURNETI IN VITRO]. 1963 Antibiotiki pmid:14078815
MOROZ AF [DIFFERENCES IN THE RESISTANCE OF BACTERIA TO ANTIBACTERIAL SUBSTANCES AND THEIR ROLE IN THE DEVELOPMENT OF DRUG-RESISTANT MICROORGANISMS]. 1964 Antibiotiki pmid:14223632
IMSHENETSKAIA VF [COMPARATIVE EVALUATION OF THE EFFECTIVNESS OF AN ERYTHROMYCIN BASE AND ERYTHROMYCIN ASCORBATE IN EXPERIMENTAL MENINGITIS]. 1963 Antibiotiki pmid:14078820
KISELEV VI [USE OF VARIOUS COMBINATIONS OF ANTIBIOTICS IN THE TREATMENT OF DIPHTHERIAL BACTERIAL CARRIAGE]. 1964 Antibiotiki pmid:14223637
VASILEVA NG [EFFECT OF ANTIBIOTIC THERAPY ON BILIARY MICROFLORA IN CHRONIC CHOLECYSTITIS PATIENTS]. 1964 Antibiotiki pmid:14223638
Ustiuzhanina IIu et al. [Purification of antibiotics by ultrafiltration through semi-permeable membranes]. 1983 Antibiotiki pmid:6418062
Katola VM [Effect of permanent magnetic field on the sensitivity of a bacterial population to antibiotics]. 1970 Antibiotiki pmid:4914041
CHERNOMORDIK AB et al. [THE SENSITIVITY OF DIPHTHERIA BACTERIA TO THE MACROLIDE ANTIBIOTICS: ERYTHROMYCIN, OLEANDOMYCIN AND SEKAZIN]. 1964 Antibiotiki pmid:14186718
ONDRACHEK Z [ON THE EFFECTIVENESS OF CERTAIN ANTIBIOTICS IN THE TREATMENT OF INFECTIOUS BILIARY DISEASES]. 1964 Antibiotiki pmid:14186720
Braginskaia PS et al. [Comparison of the efficacy of 3 methods of testing for the sterility of eye ointments with antibiotics]. 1976 Antibiotiki pmid:776070
Vasil'ev VK et al. [Pharmacokinetic characteristics and the chemotherapeutic effectiveness of a 2% ditetracycline-erythromycin eye ointment]. 1976 Antibiotiki pmid:776076
Ekisenina NI et al. [Use of prodigiozan in chronic diseases of intestine]. 1969 Antibiotiki pmid:4889845
Grekova GN [Sensitivity of Proteus vulgaris, isolated from patients with acute disorders of gastro-intestinal tract, to different antibiotics and furacillin]. 1969 Antibiotiki pmid:4891714
Smolianskaia AZ et al. [Transduction of drug resistance in clinical strains of staphylococci]. 1975 Antibiotiki pmid:124548
Brovtsyna AV [Study of sensitivity of antibiotics of microbes from the genus Shigella]. 1969 Antibiotiki pmid:4891715
Kharitonova AM [On the nephrotic action of antibiotics]. 1967 Antibiotiki pmid:4171895
Klimov AN et al. [Effect of mitomycin C, actinomycin C and some other antibiotics on the transformation of streptococci]. 1966 Antibiotiki pmid:4172492
Chernomordik AB [Antibiotic lincomycin]. 1968 Antibiotiki pmid:4894135
VaÄ­sberg GE and Meshkov MI [Treatment of patients with microbial eczema by prodigiozan in combination with antibiotics]. 1968 Antibiotiki pmid:5678111
MOROZ AF [STUDY ON THE COMBINED EFFECT OF MIXTURES OF TETRACYCLINE AND PREPARATIONS FROM THE MACROLID GROUP ON STAPHYLOCOCCI RESISTANT TO VARIOUS ANTIBIOTICS]. 1963 Antibiotiki pmid:14130402
ZAKARIAN LM [ON MODIFIED ANTIBIOTIC SENSITIVITY OF STAPHYLOCOCCI CULTIVATED WITH CANDIDA ALBICANS]. 1964 Antibiotiki pmid:14242807
PASHIN AV [STUDIES ON THE ANTIBIOTIC SENSITIVITY ENTEROPATHOGENIC INTESTINAL BACILLI AND ON ITS RELATION TO THE CARRIAGE OF SYMBIOTIC PHAGES]. 1964 Antibiotiki pmid:14242808
Baroian OV et al. [Resistance of Shigella to antibiotics]. 1974 Antibiotiki pmid:4614699
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
Calvert H et al. Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer. 2014 Anticancer Drugs pmid:24637575
Ohkura K et al. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket. 2009 Anticancer Res. pmid:19414330
Kiso S et al. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. 2000 Sep-Oct Anticancer Res. pmid:11062690
Gunics G et al. Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines. 2001 Jan-Feb Anticancer Res. pmid:11299745
OSWALD EJ et al. IN VITRO ANTISTAPHYLOCOCCAL EFFECTS OF ERYTHROMYCIN COMBINED WITH SEMISYNTHETIC PENICILLINS. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14287966
GUZE LB and KALMANSON GM EFFECT OF ERYTHROMYCIN ON IN VIVO "PROTOPLAST" INFECTION. 1964 Antimicrob Agents Chemother (Bethesda) pmid:14288026
Garrison DW et al. Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596165
Duncan IB Development of lincomycin resistance by staphylococci. 1967 Antimicrob Agents Chemother (Bethesda) pmid:5596212
TAUBMAN SB et al. EFFECT OF ERYTHROMYCIN ON PROTEIN BIOSYNTHESIS IN BACILLUS SUBTILIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274930
SELL SH and SANDERS RS THERAPY WITH ERYTHROMYCIN ESTOLATE FOR OTITIS MEDIA ASSOCIATED WITH HAEMOPHILUS INFLUENZAE INFECTION. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14274999
MOFFETT HL et al. ERYTHROMYCIN ESTOLATE AND PHENOXYMETHYL PENICILLIN IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS. 1963 Antimicrob Agents Chemother (Bethesda) pmid:14275000
Spizek J et al. Biogenetic relationship of the erythromycins and the lactone of erythromycin B. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883418
Grady JE and Stern KF Penetration of lincomycin into bone. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883427
Rasch JR and Mogabgab WJ Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5883484
Whaley HA et al. LL-A0341 A and B, new antibiotics. I. Isolation and characterization. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985292
Wilhelm JM et al. Interaction of antibiotics with ribosomes: structure-function relationships and a possible common mechanism for the antibacterial action of the macrolides and lincomycin. 1967 Antimicrob Agents Chemother (Bethesda) pmid:4970204
Perun TJ et al. Conformation of mactolide antibiotics. IV. Nuclear magnetic resonance, circular dichroism, and chemical studies of erythromycin derivatives. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396476
Jones PH et al. Chemical modifications of erythromycin antibiotics. II. Synthesis of 4'-hydroxyerythromycin A. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396478
Zinner SH et al. Erythromycin plus alkalinization in treatment of urinary infections. 1969 Antimicrob Agents Chemother (Bethesda) pmid:5396518
Weinstein MJ et al. Preliminary studies on megalomicin, a new Micromonospora-produced macrolide antibiotic complex. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735370
Paterson PY and Madden GM Occurrence and erythromycin susceptibility of penicillin-resistant Viridans streptococci in rheumatic fever patients on oral penicillin prophylaxis. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735376
McGehee RF R et al. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735385
Wick WE and Mallett GE New analysis for the therapeutic efficacy opropionyl erythromycin and erythromycin base. 1968 Antimicrob Agents Chemother (Bethesda) pmid:5735386
Kawamata J and Nakajima K Mode of action of colistin. 1965 Antimicrob Agents Chemother (Bethesda) pmid:5327517
Boyd RJ and Godzeski CW Selected antibiotic effects on the L-phase of Protus mirabilis in tissue culture. 1970 Antimicrob Agents Chemother (Bethesda) pmid:5521355
Bailly S et al. Differential modulation of cytokine production by macrolides: interleukin-6 production is increased by spiramycin and erythromycin. 1991 Antimicrob. Agents Chemother. pmid:1759822
Fujii T et al. Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells. 1996 Antimicrob. Agents Chemother. pmid:8726037
Vacher S et al. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. 2003 Antimicrob. Agents Chemother. pmid:12604552
Gorzynski EA et al. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin. 1989 Antimicrob. Agents Chemother. pmid:2524998
Pai SR et al. In vivo efficacy of the ketolide ABT-773 (cethromycin) against enterococci in a mouse peritonitis model. 2003 Antimicrob. Agents Chemother. pmid:12878548
Pestka S et al. Induction of erythromycin resistance in Staphyloccus aureus by erythromycin derivatives. 1976 Antimicrob. Agents Chemother. pmid:1259386
Diacon AH et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. 2012 Antimicrob. Agents Chemother. pmid:22391540
Barry AL et al. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). 1998 Antimicrob. Agents Chemother. pmid:9559816
Menninger JR and Coleman RA Lincosamide antibiotics stimulate dissociation of peptidyl-tRNA from ribosomes. 1993 Antimicrob. Agents Chemother. pmid:8239627
Cochetti I et al. Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I). 2005 Antimicrob. Agents Chemother. pmid:16304164
Champney WS and Tober CL Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. 1999 Antimicrob. Agents Chemother. pmid:10348746
Ednie LM et al. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). 1997 Antimicrob. Agents Chemother. pmid:9303406
Flamm RK et al. Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers. 2014 Antimicrob. Agents Chemother. pmid:24514082
Barry AL In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents. 1988 Antimicrob. Agents Chemother. pmid:3348606
Reinert RR et al. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia. 2008 Antimicrob. Agents Chemother. pmid:18378707
Mima T and Schweizer HP The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. 2010 Antimicrob. Agents Chemother. pmid:20498323
Spangler SK et al. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin. 1992 Antimicrob. Agents Chemother. pmid:1323956
Dagan R and Bar-David Y Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. 1992 Antimicrob. Agents Chemother. pmid:1605593